Ye Yuanzi, Otahal Petr, Wills Karen E, Neil Amanda L, Venn Alison J
Menzies Institute for Medical Research, University of Tasmania, Australia; Department of Pathology, Anhui Medical University, China.
Menzies Institute for Medical Research, University of Tasmania, Australia.
Cancer Epidemiol. 2018 Aug;55:61-67. doi: 10.1016/j.canep.2018.05.005. Epub 2018 May 25.
Subsequent primary cancers (SPCs) compete with first cancers and non-cancer events as the primary cause of death among cancer patients. We aimed to assess temporal trends in SPC mortality since 1980 among adult-onset cancer patients in competing risk models.
Patients registered with a first cancer in the population-based Tasmanian Cancer Registry, Australia, between 1980-2009 were followed up to December 2014. Cumulative incidence function (CIF) was used to estimate the cumulative incidence of cause-specific deaths in the presence of competing risks. The hazard ratios of SPC-specific deaths were assessed in two regression models: subdistribution hazard ratios from competing risk models (SHRs) and hazard ratios from Cox models (CHRs).
Overall, 5339 (9.3%) of 57,288 patients developed SPCs and 2494 died from SPCs during the follow-up. While the cumulative incidence of first cancer deaths at 5, 10, 15 and 20-years gradually decreased over periods of first cancer diagnosis, the cumulative incidence of SPC deaths did not. The SHRs for SPC-specific deaths increased from the reference period 1980-1984 to a peak for first cancers diagnosed in 1995-1999 (SHR = 1.18, 95%CI 1.03-1.35), before a decrease in 2005-2009 (SHR = 0.82, 95%CI 0.70-0.95) in competing risk models. However, this pattern was not consistent in CHRs. For individuals with specific first cancers, those with a first prostate cancer in 1995-1999 ha d the greatest SPC mortality risk (SHR = 2.08, 95%CI 1.29-3.36).
Competing risk models, but not Cox models, demonstrated temporal increases in SPC-specific mortality. Greater detection of non-fatal first prostate cancers appears to have contributed to this trend.
后续原发性癌症(SPC)与首次癌症及非癌症事件相互竞争,成为癌症患者死亡的主要原因。我们旨在评估1980年以来成年发病癌症患者在竞争风险模型中SPC死亡率的时间趋势。
对1980年至2009年期间在澳大利亚塔斯马尼亚州基于人群的癌症登记处登记的首例癌症患者进行随访,直至2014年12月。累积发病率函数(CIF)用于估计存在竞争风险时特定病因死亡的累积发病率。在两个回归模型中评估SPC特异性死亡的风险比:竞争风险模型的亚分布风险比(SHR)和Cox模型的风险比(CHR)。
总体而言,57288例患者中有5339例(9.3%)发生了SPC,随访期间有2494例死于SPC。虽然在首次癌症诊断后的不同时期,5年、10年、15年和20年时首次癌症死亡的累积发病率逐渐下降,但SPC死亡的累积发病率并未下降。在竞争风险模型中,SPC特异性死亡的SHR从参考期1980 - 1984年增加到1995 - 1999年诊断的首例癌症的峰值(SHR = 1.18,95%CI 1.03 - 1.35),然后在2005 - 2009年下降(SHR = 0.82,95%CI 0.70 - 0.95)。然而,这种模式在CHR中并不一致。对于患有特定首例癌症的个体,1995 - 1999年患有首例前列腺癌的个体SPC死亡风险最高(SHR = 2.08,95%CI 1.29 - 3.36)。
竞争风险模型而非Cox模型显示SPC特异性死亡率随时间增加。对非致命性首例前列腺癌的更多检测似乎促成了这一趋势。